药物发现
可扩展性
虚拟筛选
计算机科学
灵活性(工程)
计算生物学
化学数据库
化学信息学
对接(动物)
网格
分布式计算
抑制器
小分子
计算机体系结构
烯胺
缩放比例
网格计算
Web应用程序
云计算
化学图书馆
互联网
作者
Domiziana Cecchini,AkshatKumar Nigam,Ming Tang,Joana Reis,Matt Koop,Andrea Gottinger,Callum R. Nicoll,Yao Wang,Abhilash Jayaraj,Süleyman Selim Çınaroğlu,Ricarda Törner,Yehor S. Malets,Minko Gehev,Krishna M. Padmanabha Das,Kelly A. Churion,Jongwan Kim,Nidhin Thomas,Yong Li,Hyuk‐Soo Seo,Sirano Dhe‐Paganon
标识
DOI:10.1038/s41587-026-03217-x
摘要
Ultralarge virtual screenings (ULVSs) evaluate billions of molecules for drug discovery but face cost, flexibility and scalability limits. We introduce AdaptiveFlow, an open-source platform that makes ULVSs more accessible, scalable and efficient and supports artificial intelligence (AI) and machine learning (ML) method development. AdaptiveFlow provides a screening-ready version of the Enamine REAL Space, to our knowledge the largest library of ready-to-dock, drug-like molecules, comprising 69 billion compounds, also available in SELFIES format. An 18-dimensional grid of molecular properties prioritizes promising chemical subspaces, with optional active learning, reducing computational costs by orders of magnitude. AdaptiveFlow integrates >1,500 docking protocols, including GPU-accelerated and ML-based methods, and achieves near-linear scaling on up to 5.6 million CPUs in the Amazon Web Services cloud. We identified nanomolar inhibitors of two disease-relevant targets, ferroptosis suppressor protein 1 (FSP1) and poly(ADP-ribose) polymerase 1. Co-crystal structures provided mechanistic insights into FSP1 inhibition. AdaptiveFlow enables drug discovery at unprecedented scale and supports the development of AI-driven methods. Massive chemical libraries are screened computationally at scale.
科研通智能强力驱动
Strongly Powered by AbleSci AI